Non-invasive test detects CYP2C19 mutations affecting drugs such as Plavix®, Inderal®, Celexa®, Vfend®, and Losec®
(PRWeb March 17, 2016)
Read the full story at http://www.prweb.com/releases/2016/03/prweb13269952.htm
Non-invasive test detects CYP2C19 mutations affecting drugs such as Plavix®, Inderal®, Celexa®, Vfend®, and Losec®
(PRWeb March 17, 2016)
Read the full story at http://www.prweb.com/releases/2016/03/prweb13269952.htm